Earnings Call · Q1 FY2021·2020-10-29

Q1 21EPS +23.30%·Rev n/aQ4 20EPS +24.30%·Rev n/aQ3 20EPS +19.44%·Rev n/aQ2 20EPS +18.63%·Rev n/a⚠ consensus missing

RESMED INC RMD

Amy Wakeham — Vice President, Investor Relations

Michael Farrell — Chief Executive Officer

Let me now highlight a few examples of innovation and execution in support of our strategic priorities. Just a recap of our strategy priorities

Brett Sandercock — Chief Financial Officer

+6.9%1d on move date3d+12.8%5d+18.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RMD calls or request research access.

More RMD calls Browse calls Request research access